This portal is to open public enhancement requests against the products and services belonging to IBM Sustainability Software. To view all of your ideas submitted to IBM, create and manage groups of Ideas, or create an idea explicitly set to be either visible by all (public) or visible only to you and IBM (private), use the IBM Unified Ideas Portal (https://ideas.ibm.com).
We invite you to shape the future of IBM, including product roadmaps, by submitting ideas that matter to you the most. Here's how it works:
Start by searching and reviewing ideas and requests to enhance a product or service. Take a look at ideas others have posted, and add a comment, vote, or subscribe to updates on them if they matter to you. If you can't find what you are looking for,
Post an idea.
Get feedback from the IBM team and other customers to refine your idea.
Follow the idea through the IBM Ideas process.
Welcome to the IBM Ideas Portal (https://www.ibm.com/ideas) - Use this site to find out additional information and details about the IBM Ideas process and statuses.
IBM Unified Ideas Portal (https://ideas.ibm.com) - Use this site to view all of your ideas, create new ideas for any IBM product, or search for ideas across all of IBM.
ideasibm@us.ibm.com - Use this email to suggest enhancements to the Ideas process or request help from IBM for submitting your Ideas.
See this idea on ideas.ibm.com
IBM's MasDevOps (MAS CLI) currently offers automated deployment method for AWS (IPI/ROSA - self-managed and managed-hosted). We need to provide the same for Azure. The development team is aware of this lack of availability of automation for Azure. Please note that this automation is not as same as IBM's BYOL/marketplace offering.
Idea priority | High |
Needed By | Yesterday (Let's go already!) |
By clicking the "Post Comment" or "Submit Idea" button, you are agreeing to the IBM Ideas Portal Terms of Use.
Do not place IBM confidential, company confidential, or personal information into any field.
Hi Arif - We won't do this until we have an equivalent ARO FVT pipeline established in our labs, which is unlikely to happen until next year. Therefore I'm going to put this idea as future consideration for now until such time as such a pipeline is available.